Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)
Taiwan · Delayed Price · Currency is TWD 33.90
+0.05 (0.15%)
Aug 12, 2025, 1:38 PM CST
Accolade Market Cap
Taiwan Bio Therapeutics has a market cap or net worth of 2.86 billion as of August 11, 2025. Its market cap has increased by 17.52% in one year.
Market Cap
2.86B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$33.90
Market Cap Chart
Since May 13, 2022, Taiwan Bio Therapeutics's market cap has increased from 1.93B to 2.86B, an increase of 48.30%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 2.86B | -19.10% |
| Dec 31, 2024 | 3.54B | 103.07% |
| Dec 29, 2023 | 1.74B | 7.86% |
| Dec 30, 2022 | 1.62B | -16.32% |
| May 13, 2022 | 1.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.96B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 31.13B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.34B |